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Abstract: 
Objectives:  
It is well established that UK Asians typically have lower vitamin D levels than Caucasians. It is also known that 
vitamin D binding protein (DBP) is lower in some races than Caucasians. To investigate how ethnicity, skin colour 
and genetic variation affect the response to vitamin D (150,000 IU) administered to young Asian and Caucasian 
men. 
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Design:  
Prospective, single centre clinical trial 
Participants: 
Sixty young men (18-25yr) of Asian (n=30) and Caucasian (n =30) origin 
Measurements:  
We measured serum calcium, phosphate, magnesium, alkaline phosphatase, albumin, parathyroid hormone; total 
25 hydroxyvitamin D (25OHD); calculated and directly measured free 25OHD; DBP at baseline and 4 weeks; DBP 
genotype, skin colour (Fitzpatrick scale), dietary vitamin D and calcium intake at baseline; and urine 
calcium:creatinine ratio at baseline, 1 and 4 weeks. 
Results 
At baseline, Asians had lower serum total 25OHD (26.4 [13.7] vs 34.1 [12.3] nmol/l p=0.0272) and DBP (6.7 [3.4] 
vs 9.6 [4.4] nmol/l; p=0.0065) but similar free 25OHD (16.7 [10.4] vs 17.8 [7.5] pmol/l p=0.6530).  After dosing, 
ƚŽƚĂů ? ?K,ƌŽƐĞƐŝŵŝůĂƌůǇŝŶĞĂĐŚŐƌŽƵƉ ?A䌃? ?Ŷŵol/l), but measured free 25OHD rose more in Asians (18.1 [9.4] 
vs 12.2 [13.3] pmol/L p=0.0464). Lower DBP at baseline, possibly reflecting genotype differences, was associated 
with a greater change in measured free 25OHD in Caucasians, but not in Asians.  
Conclusions 
Asian compared with Caucasian males had a larger increment in measured free 25OHD following 150,000 units 
vitamin D3, possibly reflecting differences in DBP affinity for 25OHD. Ethnicity should be considered when 
devising guidelines for the treatment of vitamin D deficiency. 
Key words: 
Bio-available 25 hydroxy vitamin D, Ethnicity, Serum Measured Free 25 hydroxy vitamin D, Vitamin D binding 
protein, Vitamin D binding protein genotype, Vitamin D3. 
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MAIN TEXT FILE 
Introduction:  
Vitamin D deficiency is a term widely used but rarely defined in terms of functional outcomes. Based on 
synthesised evidence, thresholds for low dose supplementation or higher dose treatment have been 
suggested. The Scientific Advisory Committee on Nutrition Department (SACN) recommends a threshold of 25 
nmol/L for serum 25OHD for all individuals at any time of the year to protect the musculoskeletal health.[1] 
dŚĞ/ŶƐƚŝƚƵƚĞŽĨDĞĚŝĐŝŶĞĚĞĨŝŶĞƐƚŚĞƚŚƌĞƐŚŽůĚĨŽƌǀŝƚĂŵŝŶĚĞĨŝĐŝĞŶĐǇĂƐA? ? ? nmol/L.[2] The Endocrine 
Society defines the threshold for vitamin D deficiency as <50nmol/L, which would likely include more than half 
the population of the UK during winter months.[3]  
 
tŚĂƚƌĞŵĂŝŶƐƵŶĐůĞĂƌŝƐƚŚĞĞǆƚĞŶƚƚŽǁŚŝĐŚ “ŽŶĞƐŝǌĞĨŝƚƐĂůů ?ŝŶƉƌŽǀŝĚŝŶŐǀŝƚĂŵŝŶƐƵƉƉůĞmentation or 
treatment. In the UK, vitamin D deficiency is widely reported, more so in those with darker skin including those 
of African or Asian descent. The effect of ethnicity, independently of other factors, has not previously been 
considered when devising strategies and recommendations for either low dose supplementation or higher 
dose treatment. 
 
Vitamin D status is currently assessed by measuring circulating 25-hydroxyvitamin D (25OHD), which exists 
either free in the circulation (<1%), or bound to albumin or the vitamin D-binding protein (DBP). The terms 
 “ĨƌĞĞ ?ǀŝƚĂŵŝŶĂŶĚ “ďŝŽĂǀĂŝůĂďůĞ ?ǀŝƚĂŵŝŶƌĞĨĞƌƌĞƐƉĞĐƚŝǀĞůǇƚŽƵŶďŽƵŶĚ ? ?K, ?ŽƌƵŶďŽƵŶĚƉůƵƐ ? ?K,
bound to albumin. The extent to which the total measurement adequately reflects either free or bioavailable 
serum 25OHD ĂŶĚǁŚĞƚŚĞƌĂŶǇƌĞůĂƚŝŽŶƐŚŝƉďĞƚǁĞĞŶ “ƚŽƚĂů ?ĂŶĚ “ĨƌĞĞ ?ǀĂƌŝĞƐĨŽůůŽǁŝŶŐƐƵƉƉůĞŵĞŶƚĂƚŝŽŶ ?Žƌ
with other factors such as ethnicity, is unclear. Reports of higher free and bioavailable serum 25OHD for the 
same total serum 25OHD in African Americans have been challenged because of concerns regarding DBP 
measurement accuracy [12,13,15,16,17].  
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In light of this, we sought to investigate whether there were differences between serum total and directly 
measured free 25OHD concentrations between Asians and white Caucasians and the changes in these 
parameters following administration of a single dose of 150,000 IU of vitamin D3. In addition, we aimed to 
determine the effect of covariates including DBP concentration and genotype, concurrent diet and skin colour 
on both the free and total 25OHD responses, and the extent of parathyroid hormone (PTH) suppression 
following dosing.  
 
Materials and methods: 
Study design: This was an exploratory study to determine the size of the effect on serum free and total 25OHD 
of a 150,000 unit dose of vitamin D3, given to young adults from different ethnic groups (Figure 1).  
Study participants: We recruited a cohort of sixty apparently healthy young adult men from two ethnic groups - 
White Caucasian (n=30) or South/East Asian (n=30) origin. Eligibility criteria included men aged between 18 and 
25 years who were free from any condition affecting bone health, general nutrition, growth and glucose 
metabolism. Subjects with any chronic illness involving the liver and kidney, causing malabsorption, who used 
steroids, anticonvulsants, or vitamin D treatment as well supplementation or any medication that might affect 
calcium and vitamin D metabolism, were excluded. Recruitment took place within the University of Sheffield 
using a mixture of email, posters/leaflets and pre-lecture 2-minute talks. Subjects were students of the University 
of Sheffield, mostly medical and dental students. None of the study participants travelled to destinations where 
cutaneous vitamin D synthesis could have taken place during the study period. Whilst it was anticipated that 
gender should not impact on the outcome, the administration of a large dose of vitamin D3 might have had 
unexpected effects on an early stage pregnancy, thus we excluded young women.  
 
Demography and auxology: At baseline, height (without shoes to next succeeding 1mm by wall-mounted 
stadiometer [Holtain, Crymych]), weight (wearing vest and pants to nearest 0.1 kg by Marsden portable weighing 
scales, body mass index [BMI (kg/m
2
), and waist:hip circumference ratio (paper tape measure) were recorded in 
all subjects. 
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Dietary calcium and vitamin D intake: A validated 101-item food frequency questionnaire (DIET-Q) was used to 
ascertain the dietary intake of calcium and vitamin D at baseline. Mean daily calcium (grams/day) and vitamin D 
(IU/day) intake were analysed using Q Builder (V4.0) nutritional software (Tinuviel software, Llanfechell, Anglesey 
UK). 
 
Skin type, season and sun exposure: Skin type was assessed using a 6-point Fitzpatrick scale in all subjects at 
baseline [4]. Fitzpatrick 1 skin type is fair and freckled; type 6 is very dark/black.  The study was conducted in the 
UK during January and February to avoid sun exposure.  
 
Samples: 
Baseline: Fasting blood samples were collected for serum total 25OHD, free 25OHD, calcium, phosphate, 
magnesium, albumin, alkaline phosphatase, PTH, DBP and DBP genotype.  
Four weeks: All blood investigations (except DBP genotype) were repeated.  
Urinary calcium:creatinine ratio: A fasting second void urine sample for calcium:creatinine ratio was collected 
at baseline, 1 and 4 weeks after vitamin D3 administration. 
 
Vitamin D3 dosing:  
A single dose of 150,000 IU of Vitamin D3 [6 mls of Invita D3 (Consiliant) 25,000 IU/ml oral solution] was 
administered under direct supervision. We chose this dose based on the work done by Oliveri B et al where 
the authors demonstrated the safety of a single dose of 150,000 IU of vitamin D to maintain appropriate levels 
of 25OHD without causing hypercalcaemia or hypercalciuria [5].
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Laboratory methods: 
Serum total 25OHD: Serum total 25OHD levels were determined using an UPLC/Mass Spectrometer Semi-
automated hexane extraction in the Acquity Ultra Performance LC/Quattro MS (Waters) analyser. Lower limit of 
detection for 25OHD2 was 6 nmol/L and for 25OHD3 3.5 nmol/L. The interassay coefficient of variation (CV) for 
25OHD2 and 25OHD3 were 5.7% and 5.4% respectively. 
Serum free 25OHD: Free 25OHD levels were measured using an ELISA from Future Diagnostics Solutions. The 
interassay CV was 4.8%.  
Serum Vitamin D binding Protein: DBP levels were measured using an ELISA from Genways Biotech Inc. The 
interassay CV was 5.8%. 
Serum calcium, phosphate, albumin, and alkaline phosphatase; urine calcium, creatinine: Measured using Micro 
Slide Technology Colorimetric/Rate by Reflectance Spectrophotometry in the Vitros 5, 1 FS System (Ortho Clinical 
Diagnostics) analyser. The interassay CVs were: calcium (1.4%), phosphate (1.6%), albumin (2.9%), alkaline 
phosphatase (2.4%), urine calcium (1.7%) and urine creatinine (4.4%). 
Intact Parathyroid hormone (PTH): PTH was measured using Immunoassay (Chemiluminescent Microparticle 
Immunoassay) in the Architect i  ? ? ? ?^ǇƐƚĞŵ ?ďďŽƚ ? ?Wd,ĂŶĂůǇƚŝĐĂůƐĞŶƐŝƚŝǀŝƚǇA䜃?ŶŐ ?> ? ? 
DBP genotyping: A pyrosequencing assay was developed in house, using PSQ assay design software version 
1.0.6 (Qiagen), to detect two single-nucleotide polymorphisms (SNPs), rs4588 and rs7041 in the DBP gene, that 
give rise to 3 common variants of DBP (i) Gc1f (ii) Gc1s and (iii) Gc2.  All subjects were genotyped for 6 
different haplotypes - Gc1f-1f, Gc1f -1s, Gc1f-2, Gc1s-1s, Gc1s-2, and Gc2-2, ranked here in order of 25OHD 
binding affinity, highest to lowest. 
PCR and sequencing primers were as follows:   
F: 5' -ATCTGAAATGGCTATTATTTTG-3',  
R: 5' Btn -ACAGTAAAGAGGAGGTGAGTT-3',  
Seq: 5' -AAAAGCTAAATTGCCTG-3'. 
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To ensure distinct pyrosequencing signals, (~10 ng) of human genomic DNA was amplified by 47× PCR cycles 
using  OneTaq® 2X Master Mix with Standard Buffer (NEB). For each genotype determination, single-stranded 
EǁĂƐƉƵƌŝĨŝĞĚĨƌŽŵ ?ʅůŽĨWZƉƌŽĚƵĐƚƐƵƐing PyroMark Q96 Vacuum Prep Workstation (Qiagen). PCR 
products were denatured to single-stranded DNA (ssDNA) and annealed with sequencing primers. 
Pyrosequencing was then performed on a PyroMark Q96 MD Instrument according to manufacturer's 
instructions (Qiagen). Nucleotide dispensation order was as follows: DBP rs4588+rs7041 CATGTCACACACTG. 
SNP analysis was carried out using the SNP analysis software provided (Qiagen). 
 
Calculated free and bio-available 25OHD: Free and bioavailable 25OHD levels based on fixed affinity constant for 
the DBP genotype (Gc1f-1f) was calculated using the mathematical model described by Chun et al [6].  
 
Sample size: 
This was an exploratory study to determine effect size and variance; hence no formal calculation of sample 
size was undertaken.  We sought advice from the Yorkshire and Humber Research Design Service who 
suggested that a sample size of 30 per group was sufficient to undertake exploratory work of this nature.  
 
Statistical methods: 
Continuously distributed data was summarized by the median (25
th
/75
th
 centiles); categorical data by n(%). 
Missing values are tabulated but not considered otherwise in our analysis. 
Normality checks were carried out; data were generally normally or near-Normally distributed, hence 
parametric tests were used to assess differences between groups. 
To compare the groups prior to dosing, 2 sample t-tests of baseline characteristics were performed and are 
reported in Table 1. 
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 The main question of interest was whether ethnicity impacted on change in total and free 25OHD following 
dosing. Two sample t tests were carried out to compare the changes in total and free 25OHD between the 
groups. Analysis of variance was also used to determine any other statistical differences between the groups 
and adjust for covariates. Generalized linear models were used to determine statistical differences between 
response variables that had error distribution models other than normal, and to assess the interactive effect of 
ethnicity and DBP on change in free 25OHD.  
&ŝƐŚĞƌ ?ƐĞǆĂĐƚƚĞƐƚǁĂƐƵƐĞĚƚŽĐŽŵƉĂƌĞƚŚĞĐĂƚĞŐŽƌŝĐĂůĚĂƚĂ ? Graphical presentation was made by Box and 
Whisker plot. P values were used sparingly with an arbitrary threshold of 0.05(two tailed). 
We performed all our analyses using Statistical Package for the Social Sciences version 22 (SPSS by IBM), Data 
Desk
TM
 v6.2.1, and Stata v14 [7]. For method comparison between directly measured serum free 25OHD and 
calculated free 25OHD, we used Medcalc for Windows, version 8.0 (Medcalc Software, Mariekerke, Belgium) 
to perform Bland-Altman analysis[8] and Passing Bablok regression[9].  
 
Results: 
Baseline clinical characteristics 
The baseline clinical characteristics of the study subjects are shown in Table 1. The white Caucasian and Asian 
men did not differ with respect to age, weight, height, BMI and waist to hip ratio. The mean (SD) Calcium 
intake (grams/day) was adequate and equal between the Asians [1031.23(382.6)] and white Caucasians 
[1065.87(266.88)]. The median (range) vitamin D intake (IU/day) in comparison with the UK recommended 
daily intake was low and similar between the groups, 140(74,276) and 120(20,524) in Asians and white 
Caucasians respectively. White Caucasians had a Fitzpatrick skin type of 1-3 and Asians 3-5. White Caucasians 
predominantly had Gc1s-2 haplotype and did not have Gc1f-1f and Gc1f-2. South Asians predominantly had 
Gc1s-1s haplotype and East Asians Gc1f-1f haplotype. Gc2-2 and Gc1s-2 were not found in East Asians (table 
2). Table 2 shows the relationship between haplotype frequency and ethnicity. There was a significant 
ĂƐƐŽĐŝĂƚŝŽŶďĞƚǁĞĞŶƚŚĞƚǁŽ ?ƉA? ? ? ? ? ? ?ĨŝƐŚĞƌ ?ƐĞǆĂĐƚƚĞƐƚ ? ?dŚĞƌĞǁĞƌĞŵŽƌĞƐŝĂŶƐǁŝƚŚ'Đ ?Ĩ-1f haplotype 
than expected [5 vs 2.5]. Similarly, more Caucasians with Gc2-1s haplotype than expected [11 vs.8.5].  
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Table 2 shows the differences in baseline total 25OHD status between the different haplotypes and ethnicity. 
However, the numbers were too small for statistical comparison. 
 
Influence of ethnicity on measured parameters at baseline and following intervention 
Twenty-nine participants out of the 60 recruited had a serum total 25OHD level of < 30mnmol/L at baseline, of 
which 60% (18/30) were Asian and 36% (11/30) were white Caucasian (Table1). Asians had significantly lower 
serum total 25OHD and DBP levels, but similar measured and calculated free 25OHD levels compared to white 
Caucasians at baseline (Table 3). At four weeks the changes in serum total 25OHD, DBP, and calculated free 
25OHD levels were similar between Asians and white Caucasians; however the increase in directly measured 
serum free 25OHD level was significantly greater in Asians 18.1(9.4) vs 12.2 (13.3) pmol/L in Caucasians 
(p=0.0464) (Table 3) (Figure(s) 2a, 2b and 2c).  Although the observed significance was marginal, we 
considered it to be acceptable for a preliminary study. 
 
There was a significant interaction (p=<0.01) between ethnicity and mean DBP in relation to change in free 
25OHD following dosing. In Caucasians, a lower mean DBP was associated with a larger in increase in 
measured free 25OHD; this was not true for Asians, in whom the relationship of free 25OHD with mean DBP 
was positive, i.e as mean DBP increased, the change in free 25OHD also increased (Figure 2d). 
We found no clear effect of DBP haplotype within ethnic group on change in either total or free 25OHD, either 
alone or in combination with other factors.  
Baseline PTH concentration was higher in Asians than in white Caucasians (p=0.0019) (Table 3). Following 
intervention, no significant changes in PTH levels were noted in either of the groups (Table 3).  No increase in 
urine calcium: creatinine ratio was noted at either 1 or 4 weeks post intervention. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Method comparison between directly measured and calculated serum free 25OHD concentration using fixed 
affinity constant for the DBP genotype (Gc1f-1f) 
Bland-Altman plot at baseline shows clear evidence of bias and one outlying observation (Figure 3a).  Passing 
Bablok plot at baseline shows small and non significant systematic bias (intercept = 0.54, 95% CI -3.54, 3.05 
pmol/L).  There is a significant proportional bias (slope = 0.43, 95% CI 0.24, 0.71 pmol/L) (Figure 3c). 
Bland-Altman plot post supplementation shows no evidence of bias (Figure 3b). 
Passing Bablok plot post supplementation shows a large negative systematic bias (-13.29 pmol/L). This is not 
statistically significant (95% CI -33.82, 2.99 pmol/L). There is no significant proportional bias (slope =1.04, 95% 
CI 0.54, 1.70 pmol/L) (figure 3d).  
 
Relationship of PTH with total and free 25OHD 
There was a statistically significant negative correlation between PTH and total 25OHD at baseline (r=-0.442; 
p=0.0006) and post intervention (r=-0.452; p=0.0004). However, the relationship of PTH at baseline with 
measured free 25OHD did not reach significance at baseline (r=-0.245; p=0.0634) or following intervention (r=-
0.061; p=0.6446). 
 
Relationship of skin type with total and free 25OHD  
There was no statistically significant difference between skin types and baseline total 25OHD concentrations 
by one-way ANOVA (F (4,54)=2.08, p=0.0956). Post-dosing total 25OHD also did not differ between skin types. 
 
Relationship of DBP genotypes on total and free 25OHD 
There were no significant differences by DBP genotype for baseline total 25OHD (F ratio =1.0075, p=0.4225) or 
serum free 25OHD (F ratio =0.4838, p=0.7868). Following intervention, subjects with Gc1f-1s haplotype (high 
affinity for 25OHD) showed the greatest increment in serum total 25OHD (increment 60.65 (17.3) nmol/L; 
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baseline 32.9 (14.0) nmol/L). Subjects with the lowest affinity haplotype Gc2-2 had the smallest increment in 
serum total 25OHD (increment 48.9 (6.9) nmol/L, baseline 18.4 (3.6) nmol/L). The increment in serum direct 
free 25OHD levels was greatest in subjects with the Gc2-1s (16.6 (10.2) pmol/L; low affinity haplotype), and 
lowest in subjects with Gc1f-1f (10.1 (11.9) pmol/L highest affinity haplotype). None of these differences 
reached statistical significance, however.  
 
Relationship of dietary calcium and vitamin D intake with PTH, DBP, total and free 25OHD 
There was no relationship of dietary calcium intake at baseline with baseline PTH, DBP, total or free 25OHD, or 
change in any of those parameters, either for the whole group or by ethnicity. 
 
Discussion:  
We found that serum total 25OHD was low in young men of White Caucasian and Asian ethnic origin during 
winter in Sheffield and increased similarly in both groups following administration of 150,000 units of vitamin 
D3, but that measured free 25OHD increased more in those of Asian origin. We found a relationship between 
both baseline and mean DBP concentration and incremental change in measured free 25OHD according to 
ethnicity. As mean DBP rose, the incremental increase in free 25OHD reduced in Caucasians, and increased in 
Asians. This suggests that the binding affinity of DBP may vary with ethnic origin.   
There is a biochemical basis for the differences in affinity of the different DBPs for vitamin D metabolites. 
Polymorphisms in the Gc gene (codominant alleles) give rise to three major electrophoretic variants of Gc 
(Gc1f, Gc1s, and Gc2), which differ by amino acid substitutions as well as glycosylation[9].  The amino acid 
sequence of the three isoforms 1f, 1s and 2 differ at positions 152, 311, 416 and 420[11].  The position 416 
difference is functionally important as this site contains a branched trisaccharide that in turn is linked to sialic 
acid (1f), mannose (1s) or no sugar residue (2). Such post-translational modifications are likely to affect the 
properties of the isoforms. Indeed, the relative affinity constants differ, so that if 1f is assigned a value of 1, 
then the values for 1s and 2 are 0.536 and 0.321, respectively [12,6].  
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Calculated estimates of free 25OHD were found to be significantly different from direct measurements, and 
showed a systematic bias. According to the free hormone hypothesis
 
[13], the biological action of 25OHD is 
exerted by its freely-available form (<1% of the total), not by the total circulating amount which comprises 
DBP-bound (85-90%) and albumin-bound (10-15%) forms plus free. There is support also for the concept of 
bioavailable 25OHD[14], comprising the albumin-bound and free fractions, suggesting that measurement of 
free or bio-available 25OHD concentration may provide a more meaningful marker of vitamin D function than 
total [15].   
The movement of DBP-bound 25OHD to bioavailable or free forms likely depends in part on the concentration 
of DBP and its binding affinity for 25OHD. Both are known to vary significantly both by and within ethnic 
groups. A recent report by Yao et al has also demonstrated significantly lower levels of DBP (p <0.001) 
measured using a monoclonal assay (165.3+/-90.4 ug//ml) in comparison with the polyclonal assay 
(418.7+/_99.0 ug/ml) in a Chinese population [16]. Powe et al in their cross sectional study reported that black 
Americans have lower total 25OHD and DBP resulting in similar concentrations of calculated bio-available 
25OHD compared to white counterparts [14].
 
Bouillon et al showed similar results in Black Gambians 
compared to White Caucasians using the same DBP assay. In contrast, when they measured DBP using a 
polyclonal assay (as used here), in the same cohort, they did not find any difference between the groups [17].
 
Similarly, Aloia et al. reported identical concentrations of DBP between US blacks and whites, using a 
polyclonal assay [18]. Recently, Nielson et al.
 
compared the DBP assays used in the MrOS
 
[19] and MRC cohorts 
[20]
 
and characterised the molecular forms of DBP [21].
 
The authors reported that the difference in DBP levels 
between the Africans and Whites identified using a monoclonal assay disappeared when measured using 
polyclonal or proteomic methods [21]. This contrasts with our results; we found a significant difference in DBP 
levels between the Asians and White Caucasians using the polyclonal assay. Lower DBP levels have previously 
been documented in carriers of two Gc2 alleles [22-24].  We found no clear effect of genotype either at 
baseline or following intervention on serum DBP, irrespective of ethnicity. Since our population size is small 
the results in relation to DBP and genotype should be considered preliminary and thus need confirming in a 
larger population.   
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We found directly measured serum free 25OHD at baseline in Asians and Caucasians to be very similar despite 
lower total 25OHD in Asians. We hypothesized originally that the lower DBP concentrations found in the 
Asians in our cohort were likely to be the reason for their comparable levels of free 25OHD. Following 
intervention with vitamin D3, no change in DBP levels were observed in either Asians or White Caucasians 
when compared to baseline, indicating that the serum DBP concentration is not altered by single dose 
supplementation. Our findings agree with those of with Sollid, where no effect of vitamin D3 on serum DBP 
concentration was shown in an interventional trial (20,000 IU D3 weekly for a year) in Caucasians [24]. 
 
We found a higher increment in measured free 25OHD concentration in Asians following vitamin D3 
supplementation, despite a similar increment in total 25OHD concentration and no significant change in DBP 
concentration. In addition ?ƚŚĞŝŶĐƌĞŵĞŶƚĂůŝŶĐƌĞĂƐĞŝŶĂƵĐĂƐŝĂŶƐ ?ƐĞƌƵŵĨƌĞĞ ? ?K,ǁĂƐŝŶǀĞƌƐĞůǇƌĞůĂƚĞĚƚŽ
both baseline and mean DBP, whereas in Asians it was not. This implies that DBP affinity for vitamin D and its 
metabolites may be a key factor in the response of Asians to vitamin D treatment. The lack of a clear 
relationship with DBP genotype could imply that additional factors may be at play, or may be due to the small 
sample size. 
 
Alzaman et al. compared the differences in total and free 25OHD levels between Black and White Americans 
following daily D3 supplementation (2000 IU or 4000 IU) or placebo for a total of sixteen weeks in nearly 200 
diabetic subjects. The authors found similar and dose-proportionate increases in both total and free 25OHD in 
both groups [25].
 
Sollid et al. studied the relationships between serum total and free 25OHD (both directly and 
by calculation) in relation to age, sex, BMI, season and DBP genotype and their inter-relationship with the 
weekly administration of 20,000 units of D3 / placebo for a year in nearly 500 individuals. The authors found 
that serum DBP was not affected by vitamin D supplementation. They demonstrated that age, sex and DBP 
concentration did not affect increment in vitamin D parameters, following supplementation [24].
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If serum free 25OHD increases disproportionately in some ethnic groups following vitamin D administration, is 
this a problem? There is another step beyond 25-hydroxylation in producing the biologically active form of 
vitamin D (1,25(OH)2D), and this step is highly regulated to protect against hypercalcaemia. The finding here 
that PTH did not decrease as expected in White Caucasians as both free and total serum 25OHD increased is 
puzzling. However, PTH did decrease in the Asian group; this suggests that the greater increase in free 25OHD 
in Asians may have broader biological significance in terms of calcium metabolism, perhaps reflecting 
increased calcium absorption. Asians had lower baseline total serum 25OHD, and are more likely (as a 
population group) to receive treatment. The concern would be therefore that significantly increasing calcium 
absorption might have unexpected and undesirable consequences in an ethnic group already at higher risk for 
cardiovascular and renal disease. 
 
In the method comparison between the calculated and directly measured serum free 25OHD using fixed 
affinity constant for the DBP genotype, there was a positive but not significant systematic bias at baseline. Post 
supplementation the systematic bias was negative and also non-significant.  We cannot explain this finding. 
This may be due to small sample size (figure 3a,b,c,d).  
 
Strengths and Limitations: 
Ours is the first interventional study reported so far, studying the effects of single dose of vitamin D3 on serum 
total 25OHD, DBP and free 25OHD concentration in both Asians and Caucasians. The main limitation of our 
study is the small sample size; hence we had an insufficient statistical power to demonstrate the influence of 
skin types or DBP genotypes on serum 25OHD (total and free) with or without vitamin D3 supplementation. We 
conducted the study exclusively in young healthy males; hence our study findings may not be applicable to 
conditions associated with variation in DBP levels such as gender, pregnancy, liver disease and infections, and 
may not necessarily be applicable across all ages. We also included no functional outcome measures. 
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Conclusion: 
Our primary aim was to determine the size of the effect of vitamin D supplementation in different ethnic groups. 
/ŶĂŶĞƌĂŽĨ “ƉƌĞĐŝƐŝŽŶŵĞĚŝĐŝŶĞ ?ǁĞƐŚŽƵůĚďĞĂďůĞƚŽďĞƚƚĞƌƚĂƌŐĞƚǀŝƚĂŵŝŶƚƌĞĂƚŵĞŶƚ ?ZĂƚŚĞƌƚŚĂŶĂĚŽƉƚŝŶŐĂ
 “ŽŶĞƐŝǌĞĨŝƚƐĂůů ?ƉŽůŝĐǇ ?ǁĞ should aim to develop measurements that accurately reflect vitamin D status across 
all ethnic groups, and use these to guide treatment for relevant functional outcomes. 
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Title: Figure 1. Study design 
  
Legend: Figure 1 showing the design of the study 
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Title: Figure(s) 2a,b,c: Change in Total, Free 25OHD and DBP following vitamin D dosing. 
Figure 2d: Change in serum free 25OHD according to mean DBP 
 
Legend: Figure(s) 2a,2b,2c show the change in total, free 25OHD and VDBP following vitamin 
D dosing. Three-part box plot showing ethnicity in X-axis and change in Total 25OHD, VDBP 
and Free 25OHD in Y-axis. Figure 2d shows the change in serum free 25OHD according to 
mean DBP with shaded circles representing Caucasians and clear circles Asians. 
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Title: Figure (s) 3a.b.c.d. Method comparison: Direct  vs. Calculated Free 25OHD-post 
supplementation (using fixed affinity constants) 
 
 
 
 
 
 
Legend: 
Figure 3a and 3b show the Bland-Altman plots. Bold line indicates mean difference with 95% limits 
of agreement on either side. Figure 3a demonstrates systematic bias between calculated (using fixed 
affinity constants) and directly measured serum free 25OHD at baseline and figure 3b, which is post 
supplementation, does not. Mean serum free 25OHD (directly measured) is represented in X axis 
and the difference between the directly measured and calculated free 25OHD is represented on the 
Y-axis.  Bland-Altman plots the mean of X and Y versus the difference between X and Y.  
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Figure(s) 3c and 3d show the Passing and Bablok plots. Bold line indicates the calculated regression. 
With 95% CI either side. The line of no difference is drawn at 45 degrees.  
Figure 3c demonstrates no systematic bias but a significant proportional bias at baseline. Figure 3d 
demonstrates neither systematic nor proportional bias post supplementation. Serum free 25OHD 
(directly measured) is represented in X axis and the calculated free 25OHD (using fixed affinity 
constants) represented on the Y-axis. Passing and Bablok is a nonparametric regression for method 
comparison.  It fits a straight line between two variables (X and Y) where both are measured with 
error. The intercept of the straight line represents the systematic bias between X and Y.  The 
null hypothesis is zero intercept. If the 95% confidence (CI) crosses zero the systematic bias is not 
statistically significant. The slope measures the amount of proportional bias.  The null hypothesis is a 
slope of one.  If the 95% CI cuts across on the proportional bias is not statistically significant. If the 
two methods are identical, they same they will share a common intercept (zero) and a common 
slope (one).   
 
Title: Table 1. Baseline demographics table, mean (SD) 
  
Whites 
  
Asians 
  
P value 
Study population 30 30 - 
Age (years) 21.43 (1.54) 22.33 (1.44) 0.66 
Weight (kg) 76.97 (9.16) 70.77 (8.34) 0.34 
Height (cms) 179.95 (5.59) 175.77(5.6) 0.95 
BMI 23.76 (2.51) 22.89 (2.30) 0.61 
Waist : Hip ratio 0.81 (0.05) 0.88 (0.09) 0.30 
Calcium intake (gms/day) 1065.87 (266.88) 1031.23 (382.6) 0.28 
Vitamin D intake (iu/day)* 120 (20, 524) 140 (74,276) 0.29 
Fitzpatrick skin grade 1 - 3 3 - 5 - 
Serum Calcium (mmol/L) 2.31 (0.06) 2.30 (0.05) 0.49 
Serum Phosphate (mmol/L) 1.38 (0.19) 1.36 (0.15) 0.74 
Albumin (g/L) 44.2 (2.2) 43.7 (1.7) 0.32 
 
Legend: Table 1 showing the baseline demographic data and the values are expressed in 
mean (SD) with the p values. 
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Title: Table 2.  Haplotype frequencies by ethnicity and median 25OHD concentration at baseline  
 
Haplotype   Caucasian      Asian Total Haplotype Caucasian Asian 
Median Baseline 25OHD concentration 
(nmol/L) 
Gc1f-1f Obs         0 
Exp         2.5 
5 
2.5 
5 Gc1f-1f - - 
Gc1s-1f Obs         9 
Exp         7.5 
6 
7.5 
15 Gc1s-1f 31.6 20.4 
Gc1s-1s Obs         9 
Exp          8.5 
8 
8.5 
17 Gc1s-1s 40.8 20.4 
Gc2-1f Obs         0 
Exp         1.5 
3 
1.5 
3 Gc2-1f - - 
Gc2-1s Obs        11 
Exp          8.5 
6 
8.5 
17 Gc2-1s 33.2 24 
Gc2-2 Obs         1     
Exp         1.5 
2 
1.5 
3 Gc2-2 22.4 16.4 
Total  30 30 60 &ŝƐŚĞƌ ?ƐĞǆĂĐƚƚĞƐƚ ?Ɖс ? ? ? ? ? 
 
Legend: Table 2 showing the haplotype frequencies by ethnicity as well the difference in median 
25OHD concentration (nmol/L) between Caucasians and Asians based on their haplotypes. 
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Title: Table 3. Results showing serum total and free 25OHD levels, estimated 25OHD and PTH levels 
at baseline and increment post supplementation, mean and SD 
 
  Serum Total  
25OHD (nmol/L) 
Serum DBP 
(umol/L) 
Measured Free 
25OHD (pmol/L) 
Calculated Free 
 
25OHD(pmol/L
) 
PTH  
(ng/L) 
Baseline Caucasians 34.1 (12.3) 6.6 (3.0) 17.8 (7.5) 13.6 (7.8) 44.6 (14.2) 
  Asians 26.3 (13.7) 4.7 (2.3) 16.7 (10.4) 11.9 (6.8) 69.8 (38.6) 
*p-value <0.05 p value *0.004 *0.001 0.65 0.38 *0.0019 
Increment Caucasians 56.7 (18.3) 0.31 (2.0) 12.2 (13.3) 24.4 (14.5) 2.2 (14.2) 
  Asians 56.2 (12.6) 0.24 (2.0) 18.1 (9.4) 29.4 (20.1) - 4.7 (27.7) 
*p-value <0.05 p value 0.90 0.90 *0.0464 0.29 0.24 
 
Legend: Table 3 showing serum total and free 25OHD levels [both measured and calculated], vitamin 
D binding protein (DBP) and parathyroid hormone (PTH) levels at baseline and their increment post 
supplementation, expressed in mean (SD).  
